直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

The New Prior User Rights Defense: How Often Will It Be Asserted?

June 11, 2013

Authored and Edited by Anthony A. Hartmann

Before the America Invents Act (AIA), the prior-user defense to infringement was limited to “method[s] of doing or conducting business.” While rarely relied on during litigation, the defense allowed the continued use of a business method in secret despite a later issued patent. Under the AIA, congress sought to expand the scope of the prior user rights under 35 U.S.C. § 273 to be commensurate with protections in many other countries.

The prior user defense now applies to any process, as well as any “machine, manufacture, or composition of matter used in a manufacturing or other commercial process,” so long as this subject matter is “commercially used” at least one year before the effective filing date of the claimed invention. But will this broadened language substantially expand the use of § 273? Possibly no.

During consideration of the AIA, Senator Leahy commented on the scope of the revised defense, noting that “[t]he phrase ‘commercially used the subject matter’ is intended to apply broadly, and to cover a person’s commercial use of any form of the subject matter.” 157 CONG. REC S5440 (daily ed. Sept. 8, 2011). But even interpreted broadly, the defense would likely not be relevant to trade secrets embodied in products sold to consumers because, “[a]s soon as the product is sold to the public, any invention that is embodied or otherwise inherent in that product becomes prior art and cannot be patented by another party, or even by the maker of the product after the grace period has expired.” Id. Further, the requirement for clear and convincing evidence of good faith “commercial use” without derivation or abandonment; the exception for certain University-related patents; the increased risk of paying attorney’s fees; and other provisions will make trade secret holders pause before asserting the defense.

In the end, the § 273 defense will likely be limited to processes or devices whose use is confined within the walls of businesses—in other words, inventions that have long been, and will continue to be, the typical subject of trade secret protections. As patent holders rarely know whether their competitors are practicing such inventions in secret, they will continue to infrequently become the subject of patent litigation. Thus, despite the broadened scope of § 273, the assertions of the prior user defense may be rare.

Related Practices

Trade Secrets

Contacts

Anthony A. Hartmann
Of Counsel
Washington, DC
+1 202 408 4275
Email

Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP